EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line

Thao Nguyen iD, Tomomi Aida, Yuka Iijima-Yamashita, Minori Tamai, Akiko Nagamachi, Keiko Kagami, Chiaki Komatsu, Shin Kasai, Koshi Akahane iD, Kumiko Goi, Toshiya Inaba, Masashi Sanada und 1 weitere

Cancer Science · 2024

DOI: 10.1111/cas.16162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Thao Nguyen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Gene Editing, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Mutation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In childhood acute lymphoblastic leukemia (ALL), TP53 gene mutation is associated with chemoresistance in a certain population of relapsed cases. To directly verify the association of TP53 gene mutation with chemoresistance of relapsed childhood ALL cases and improve their prognosis, the development of appropriate human leukemia models having TP53 mutation in the intrinsic gene is required. Here, we sought to introduce R248Q hotspot mutation into the intrinsic TP53 gene in an ALL cell line, 697, by applying a prime editing (PE) system, which is a versatile genome editing technology. The PE2 system uses an artificial fusion of nickase Cas9 and reverse‐transcriptase to directly place new genetic information into a target site through a reverse transcriptase template in the prime editing guide RNA (pegRNA). Moreover, in the advanced PE3b system, single guide RNA (sgRNA) matching the edited sequence is also introduced to improve editing efficiency. The initially obtained MDM2 inhibitor‐resistant PE3b‐transfected subline revealed disrupted p53 transactivation activity, reduced p53 target gene expression, and acquired resistance to chemotherapeutic agents and irradiation. Although the majority of the subline acquired the designed R248Q and adjacent silent mutations, the insertion of the palindromic sequence in the scaffold hairpin structure of pegRNA and the overlap of the original genomic DNA sequence were frequently observed. Targeted next‐generation sequencing reconfirmed frequent edit errors in both PE2 and PE3b‐transfected 697 cells, and it revealed frequent successful edits in HEK293T cells. These observations suggest a requirement for further modification of the PE2 and PE3b systems for accurate editing in leukemic cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Gene EditingPrecursor Cell Lymphoblastic Leukemia-LymphomaMutationHumansCell Line, TumorDrug Resistance, NeoplasmCRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsProto-Oncogene Proteins c-mdm2

Stichwörter der Autor:innen

TP53 gene mutationacute lymphoblastic leukemiagenome editingprime editing systemtreatment resistance

Substanzen

Tumor Suppressor Protein p53TP53 protein, humanRNA, Guide, CRISPR-Cas SystemsProto-Oncogene Proteins c-mdm2MDM2 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Department of Advanced Diagnosis, Clinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan.
  • Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Higashihiroshima, Japan.

ORCID-Profile: Thao Nguyen, Koshi Akahane

Förderung

  • JSPS
  • Japan Society for the Promotion of Science

Zitieren

APA

Nguyen, T., Aida, T., Iijima-Yamashita, Y., Tamai, M., Nagamachi, A., Kagami, K., Komatsu, C., Kasai, S., Akahane, K., Goi, K., Inaba, T., Sanada, M., & Inukai, T. (2024). Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line. Cancer Science. https://doi.org/10.1111/cas.16162

Vancouver

Nguyen T, Aida T, Iijima-Yamashita Y, Tamai M, Nagamachi A, Kagami K, et al. Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line. Cancer Science. 2024. doi:10.1111/cas.16162

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Thao and Aida, Tomomi and Iijima-Yamashita, Yuka and Tamai, Minori and Nagamachi, Akiko and Kagami, Keiko and Komatsu, Chiaki and Kasai, Shin and Akahane, Koshi and Goi, Kumiko and Inaba, Toshiya and Sanada, Masashi and Inukai, Takeshi},
  title = {Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16162}
}
Kostenlos starten →